
    
      Every participant will receive oral Euphorbia kansui Pill every day. The dose of Euphorbia
      kansui will be 1g each time for 7 consecutive days. All participants will keep their
      antiretroviral therapy during this study.

      Each step of this study will last for 21 days, involving 7 study visits (Screening,Day 0, 1,
      3, 5, 7, 14, 21) for every participant. At the screening visit, participants will give a
      medical history and will undergo a physical exam; blood samples will be collected.
      Participants will undergo pharmacodynamic sampling which will require that blood be collected
      12 hours after kansui Pill administration on Day 1, 3, 5,7. If participants agree, their
      blood samples may be stored for future research.
    
  